Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Commonwealth Bank of Australia Stock (ASX:CBA): Share Price, Rate-Hike Outlook and Analyst Forecasts as of 21 December 2025

Commonwealth Bank of Australia Stock (ASX:CBA): Share Price, Rate-Hike Outlook and Analyst Forecasts as of 21 December 2025

Commonwealth Bank of Australia (CBA) is heading into the final stretch of 2025 with the same two forces pulling its share price in opposite directions: a market-leading retail banking franchise that investors treat like a “core holding,” and a valuation that many analysts still struggle to justify. Because 21 December 2025 falls on a Sunday, Australian equities aren’t trading today. The most recent pricing snapshot is therefore from Friday’s close (19 December 2025)—and it shows CBA stabilising after a volatile second half of the year, even as rate expectations swing again. Intelligent Investor CBA share price today: where Commonwealth Bank
21 December 2025
·····
BHP Group Ltd Stock (ASX:BHP, NYSE:BHP): Latest News, Forecasts and Analyst Views as of 21 December 2025

BHP Group Ltd Stock (ASX:BHP, NYSE:BHP): Latest News, Forecasts and Analyst Views as of 21 December 2025

BHP Group Ltd stock is ending the week with investors juggling a familiar (and very 2025) mix of forces: a copper rally flirting with record territory, a slower-but-still-hungry China buying iron ore at scale, fresh legal headlines tied to the Mariana/Fundão disaster, and a capital-recycling deal that signals BHP wants more balance-sheet flexibility without giving up operational control. Because today is Sunday, 21 December 2025, major markets are closed—so the most actionable “today” read on BHP is really a synthesis of the latest confirmed developments and published forecasts up to this date. BHP share price check: where the stock stands
21 December 2025
··
Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston Holdings, Inc. (NYSE: LW) is back in the market’s spotlight this weekend—and not because investors suddenly stopped liking French fries. After reporting second-quarter fiscal 2026 results that beat Wall Street expectations on revenue and adjusted earnings, Lamb Weston shares still fell sharply as investors zeroed in on what management said comes next: continued discounting, unfavorable price/mix, and higher international manufacturing costs that could keep profitability under pressure into the back half of the year. Barron’s+2Reuters+2 Below is what actually happened, what the company guided for fiscal 2026, and how analysts and market watchers are framing the bull case
20 December 2025
·····
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine, Inc. (NASDAQ: IRON) stock is seeing a classic “biotech catalyst storm” on Dec. 20, 2025: big intraday swings, headline-driven volatility, and analysts arguing over whether the market is repricing risk or merely repricing uncertainty. As of the latest trading data available, IRON was around $80.04, down roughly 11.5% versus the prior close, after trading as high as $94.60 and as low as $71.46 on heavy volume (about 4.22 million shares). The immediate trigger: a report-driven debate about the FDA’s new fast-track voucher process and whether Disc’s lead drug candidate, bitopertin, remains on the clean, accelerated path bulls were
20 December 2025
·····
Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation (NASDAQ: APLD) is ending the week the way only an AI-infrastructure “picks-and-shovels” stock can: with a bruising selloff, a sharp rebound, and investors arguing about whether the company is building the future—or building a debt tower during an interest-rate era that does not forgive. On Friday, Dec. 19, APLD surged 16.53% to close at $27.85, after trading between $24.33 and $27.89 in the session, according to AAII’s recap. aaii.com That jump followed a volatile stretch where the market’s mood swung between “AI data centers are inevitable” and “okay, but who pays for all this concrete, copper, power,
20 December 2025
····
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ended Friday’s session sharply higher after announcing a blockbuster rare-disease acquisition that immediately reframed the company’s growth story. Shares closed at $61.15, up about 17.7% on the day, with trading volume far above typical levels—classic “big-news repricing” behavior. Yahoo Finance The catalyst: BioMarin’s agreement to buy Amicus Therapeutics (NASDAQ: FOLD) for $14.50 per share in cash, valuing the deal at approximately $4.8 billion. BioMarin says the acquisition adds two marketed, growing therapies—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease)—plus U.S. rights to DMX-200 (a Phase 3 kidney-disease asset), while also resolving a key piece
20 December 2025
····
Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc stock is closing out 2025 with the kind of headline stack investors usually reserve for a comeback movie: record full‑year profit and revenue, investment‑grade leverage metrics, the first dividend in more than five years, and a proposal to simplify its unusual dual‑listed structure. The market’s initial reaction was loud—CCL finished Friday (Dec. 19) up about 9.8% at $31.12 after trading as high as $31.49, with volume north of 83 million shares. StockAnalysis This weekend’s coverage (Dec. 20, 2025) has focused on three big questions for anyone watching Carnival stock: Below is what’s new, what’s forecast, and
20 December 2025
·····
Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Corporation (NASDAQ: RKLB) closed at a fresh all-time high on Friday, December 19, after landing its largest contract to date: a major U.S. Space Force-linked award to build missile-defense satellites for the Space Development Agency (SDA). The move capped off a volatile, news-packed stretch for the company—one that also included a high-profile U.S. Space Force launch completed months ahead of schedule, a first dedicated mission for Japan’s space agency, and continued drumbeat updates on Rocket Lab’s next-generation Neutron rocket program. SDA+3MarketWatch+3Investing.com+3 As of Saturday, December 20, 2025 (U.S. markets closed), the latest official close being digested by investors
20 December 2025
·····
Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

December 20, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) is back in the spotlight after a sharp, high-volume move to close Friday, December 19, 2025 at $9.22, up 18.21% in a single session. Trading volume also spiked to roughly 125 million shares, a “something big is happening” kind of number for a company of this size. Ondas Holdings Inc. The rally didn’t arrive out of nowhere. Over the past three weeks—especially in mid-December—Ondas has stacked a rapid sequence of defense-and-security-focused headlines: leadership expansion, acquisition integration, a European industrial cooperation push, counter-drone orders, and an AI-driven demining pilot with measurable real-world
20 December 2025
·····
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December 20, 2025, EWTX is being widely quoted around $25.55—a level reached after a powerful jump in the prior U.S. session. StockAnalysis+1 What matters for readers tracking the stock isn’t just the price print. It’s the why: a late-stage neuromuscular story (sevasemten), a closely watched cardiovascular program (EDG-7500), and a pipeline that can re-rate quickly on clinical updates—up or down. PR
20 December 2025
···
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave, Inc. (NASDAQ: CRWV) has snapped back sharply after a bruising second half of 2025, with the AI infrastructure stock jumping about 22.5% in the latest session to around $83, after trading between roughly $70.70 and $84.19 on heavy volume. The move caps a week dominated by two storylines investors keep circling: validation (government and Wall Street endorsements) versus vulnerability (debt, dilution risk, and execution bottlenecks). Here’s what’s driving CoreWeave stock right now—and what matters most heading into 2026. Why CoreWeave stock jumped: Citi’s “Buy” (with a warning label) and the DOE Genesis Mission Citi resumes coverage: bullish rating, lower
20 December 2025
·····
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) is suddenly trading like a classic merger-arbitrage stock after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire the company in an all-cash deal valued at roughly $4.8 billion. BioMarin’s offer of $14.50 per share sparked a sharp re-pricing of Amicus shares, which have been hovering just below the bid as investors weigh deal timing, closing risk, and what the buyout means for Amicus’ two commercial rare-disease franchises—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease). SEC+1 Below is a detailed breakdown of the latest news (as of 20.12.2025), plus the most relevant
20 December 2025
·····
1 … 595 596 597 598 599 … 887

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop